Literature DB >> 11118560

Sertaconazole in the treatment of mycoses: from dermatology to gynecology.

J Torres1, M Márquez, F Camps.   

Abstract

Sertaconazole is a pharmaceutical product in the form of a cream, gel, powder and solution for dermatological use and vaginal cream, tablets and ovules for gynecological use. It is marketed in 24 countries and registered in a further 22. The active ingredient is 2% sertaconazole nitrate. Sertaconazole nitrate is an azole antifungal agent, with notable antifungal activity. Its molecule has a highly lipophilic fragment. This is a review of the efficacy and safety of all pharmaceutical forms of sertaconazole in order to provide data on vaginal sertaconazole for marketing purposes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118560     DOI: 10.1016/s0020-7292(00)00349-0

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  5 in total

1.  Dermatomycoses of the glabrous skin : a double-blind, randomised, comparative trial of sertaconazole 2% cream once daily versus vehicle.

Authors:  Rudy Susilo; Hans C Korting; Uwe Phillip Strauss
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

2.  Investigation of the Dermal Absorption and Irritation Potential of Sertaconazole Nitrate Anhydrous Gel.

Authors:  Mahima Manian; Kumpal Madrasi; Ayyappa Chaturvedula; Ajay K Banga
Journal:  Pharmaceutics       Date:  2016-07-07       Impact factor: 6.321

3.  In Situ Swelling Formulation of Glycerol-Monooleate-Derived Lyotropic Liquid Crystals Proposed for Local Vaginal Application.

Authors:  Martine Tarsitano; Antonia Mancuso; Maria Chiara Cristiano; Donatella Paolino; Massimo Fresta
Journal:  Molecules       Date:  2022-09-23       Impact factor: 4.927

4.  Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: a pilot study.

Authors:  Hr Jerajani; C Janaki; Sharath Kumar; Meghana Phiske
Journal:  Indian J Dermatol       Date:  2013-01       Impact factor: 1.494

5.  Fabrication and Characterization of Sertaconazole Nitrate Microsponge as a Topical Drug Delivery System.

Authors:  V V Pande; N A Kadnor; Rupali N Kadam; S A Upadhye
Journal:  Indian J Pharm Sci       Date:  2015 Nov-Dec       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.